drugset / Trial / NCT05432115

Bismuth Quadruple Therapy for Helicobacter Pylori Rescue Therapy of Different Tetracycline Doses and Frequencies.

NCT05432115

RandomizedParallel-groupOpen-labelTreatment

Summary

The researchers collect H.pylori-positive patients who need rescue therapy from the outpatient clinic. The subjects were randomized to receive a dose and frequency of tetracycline 500mg tid or qid of bismuth quadruple eradication therapy. 6-8 weeks after treatment, the subjects will re-take the 13C-urea breath test. Calculate the eradication rates, adverse reaction rates and patient compliance of each group.

Timeline

Start
2022-06-25
Primary completion
2023-08
Completion
2023-10

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Tetracycline Unknown 500 mg
Background Amoxicillin Other / unclassified 1000 mg
Background Bismuth Potassium Citrate Unknown
Background Esomeprazole Small molecule 40 mg